At close: December 16 at 4:00:01 PM EST
After hours: 7:59:26 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-33,074.0000
-31,410.0000
-23,809.0000
-26,021.0000
-10,417.0000
Investing Cash Flow
--
-5,500.0000
-4,500.0000
--
--
Financing Cash Flow
50,136.0000
22,315.0000
24,079.0000
12,074.0000
38,442.0000
End Cash Position
21,131.0000
2,630.0000
17,225.0000
21,455.0000
35,402.0000
Capital Expenditure
--
-5,500.0000
-4,500.0000
--
--
Issuance of Capital Stock
49,496.0000
22,225.0000
23,994.0000
9,005.0000
29,599.0000
Free Cash Flow
-33,074.0000
-36,910.0000
-28,309.0000
-26,021.0000
-10,417.0000
12/31/2020 - 3/12/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1244.HK 3D MEDICINES
3.200
+2.56%
ATOS Atossa Therapeutics, Inc.
1.0700
-4.46%
GALT Galectin Therapeutics Inc.
2.3100
+9.48%
GLSI Greenwich LifeSciences, Inc.
12.90
-4.52%
ICU SeaStar Medical Holding Corporation
1.8400
-7.54%
EYEN Eyenovia, Inc.
0.0816
-2.28%
CLRB Cellectar Biosciences, Inc.
0.2577
-0.88%
AVXL Anavex Life Sciences Corp.
9.18
+8.51%
BCTX BriaCell Therapeutics Corp.
0.6081
-7.86%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.3000
-11.88%